Vitamin D2 supplementation induces the development of aortic stenosis in rabbits: Interactions with endothelial function and thioredoxin-interacting protein

European Journal of Pharmacology

Volumn 590, Issue 1-3, 2008, Pages 290-296

  Ngo, Doan T M ^a   Stafford, Irene ^a   Kelly, Darren J ^b   Sverdlov, Aaron L ^a   Wuttke, Ronald D ^a   Weedon, Helen ^c   Nightingale, Angus K ^a   Rosenkranz, Anke C ^a   Smith, Malcolm D ^c   Chirkov, Yuliy Y ^a   Kennedy, Jennifer A ^a   Horowitz, John D ^a  

^a QUEEN ELIZABETH HOSPITAL   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c FLINDERS UNIVERSITY   (Australia)

Author keywords

Aortic valve stenosis; Endothelial function; Nitric oxide; Redox stress; Thioredoxin interacting protein; Vitamin D

Indexed keywords

ERGOCALCIFEROL; NITRIC OXIDE; THIOREDOXIN;

ANALYSIS OF VARIANCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA STENOSIS; AORTA VALVE STENOSIS; ARTERY ENDOTHELIUM; ARTICLE; CALCIFICATION; CELL INFILTRATION; CONTROLLED STUDY; ECHOCARDIOGRAPHY; ENDOTHELIAL DYSFUNCTION; HEMODYNAMICS; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; LIPID STORAGE; MACROPHAGE; MALE; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRESSURE GRADIENT; PRIORITY JOURNAL; PROTEIN INTERACTION; QUANTITATIVE ANALYSIS; RABBIT; TREATMENT DURATION; VITAMIN SUPPLEMENTATION;

ANIMALS; AORTA; AORTIC VALVE STENOSIS; CARRIER PROTEINS; DISEASE MODELS, ANIMAL; ECHOCARDIOGRAPHY; ENDOTHELIUM, VASCULAR; ERGOCALCIFEROLS; HYPERCHOLESTEROLEMIA; IMMUNOHISTOCHEMISTRY; MALE; OXIDATIVE STRESS; RABBITS;

EID: 48049119233     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2008.05.051     Document Type: Article

References (37)

1. Aronow W.S., Schwartz K.S., and Koenigsberg M. Correlation of serum lipids, calcium, and phosphorus, diabetes mellitus, and history of systemic hypertension with presence or absence of calcified or thickened aortic cusps or root in elderly patients. Am. J. Cardiol. 59 (1987) 998-999
2. Aronow W.S., Ahn C., Shirani J., and Kronzon I. Comparison of frequency of new coronary events in older subjects with and without valvular aortic sclerosis. Am. J. Cardiol. 83 (1999) 599-600
3. Boger R.H. The emerging role of asymmetric dimethylarginine as a novel cardiovascular risk factor. Cardiovasc. Res. 59 (2003) 824-833
4. Chirkov Y.Y., Holmes A.S., Willoughby S.R., Stewart S., and Horowitz J.D. Association of aortic stenosis with platelet hyperaggregability and impaired responsiveness to nitric oxide. Am. J. Cardiol. 90 (2002) 551-554
5. Chirkov Y.Y., Mishra K., Chandy S., Holmes A.S., Kanna R., and Horowitz J.D. Loss of anti-aggregatory effects of aortic valve tissue in patients with aortic stenosis. J. Heart Valve Dis. 15 (2006) 28-33
6. Cimini M., Boughner D.R., Ronald J.A., Aldington L., and Rogers K.A. Development of aortic valve sclerosis in a rabbit model of atherosclerosis: an immunohistochemical and histological study. J. Heart Valve Dis. 14 (2005) 365-375
7. De la Lande I.S., Stafford I., and Horowitz J.D. Tolerance induction by transdermal glyceryl trinitrate in rats. Eur. J. Pharmacol. 374 (1999) 71-75
8. De la Lande I.S., Stepien J.M., Philpott A.C., Hughes P.A., Stafford I., and Horowitz J.D. Aldehyde dehydrogenase, nitric oxide synthase and superoxide in ex vivo nitrate tolerance in rat aorta. Eur. J. Pharmacol. 496 (2004) 141-149
9. Drolet M.C., Arsenault M., and Couet J. Experimental aortic valve stenosis in rabbits. J. Am. Coll. Cardiol. 41 (2003) 1211-1217
10. Drolet M.C., Roussel E., Deshaies Y., Couet J., and Arsenault M. A high fat/high carbohydrate diet induces aortic valve disease in C57BL/6J mice. J. Am. Coll. Cardiol. 47 (2006) 850-855
11. Han S.H., Jeon J.H., Ju H.R., Jung U., Kim K.Y., Yoo H.S., Lee Y.H., Song K.S., Hwang H.M., Na Y.S., Yang Y., Lee K.N., and Choi I. VDUP1 upregulated by TGF-beta1 and 1,25-dihydorxyvitamin D3 inhibits tumor cell growth by blocking cell- cycle progression. Oncogene 22 (2003) 4035-4046
12. Heresztyn T., Worthley M., and Horowitz J.D. Determination of l-arginine and NG, NG - and NG, NG'-dimethyl-l-arginine in plasma by liquid chromatography as AccQ-Fluor fluorescent derivatives. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 805 (2004) 325-329
13. Hines T.G., Jacobson N.L., Beitz D.C., and Littledike E.T. Dietary calcium and vitamin D: risk factors in the development of atherosclerosis in young goats. J. Nutr. 115 (1985) 167-178
14. Jono S., Nishizawa Y., Shioi A., and Morii H. 1,25-dihydroxyvitamin D3 increases in vitro vascular calcification by modulating secretion of endogenous parathyroid hormone-related peptide. Circulation 98 (1998) 1302-1306
15. Junn E., Han S.H., Im J.Y., Yang Y., Cho E.W., Um H.D., Kim D.K., Lee K.W., Han P.L., Rhee S.G., and Choi I. Vitamin D3 up-regulated protein 1 mediates oxidative stress via suppressing the thioredoxin function. J. Immunol. 164 (2000) 6287-6295
16. Kennedy J.A., Hua X., Rosenkranz A.C., Murphy G.A., Mishra K., and Horowitz J.D. Nitric oxide donors and PGE1 inhibit calcification of aortic valve interstitial cells. Eur. Heart J. 27 (2006) 573 (Abstract Supplement)
17. Kraan M.C., Haringman J.J., Ahern M.J., Breedveld F.C., Smith M.D., and Tak P.P. Quantification of the cell infiltrate in synovial tissue by digital image analysis. Rheumatology (Oxford) 39 (2000) 43-49
18. Lehr H.A., Mankoff D.A., Corwin D., Santeusanio G., and Gown A.M. Application of photoshop-based image analysis to quantification of hormone receptor expression in breast cancer. J. Histochem. Cytochem. 45 (1997) 1559-1565
19. Malergue M.C., Urena P., and Prieur P. Incidence and development of aortic stenosis in chronic hemodialysis: an ultrasonographic and biological study of 112 patients. Arch. Mal. Coeur. Vaiss. 90 (1997) 1595-1601
20. Mills W.R., Einstadter D., and Finkelhor R.S. Relation of calcium-phosphorus product to the severity of aortic stenosis in patients with normal renal function. Am. J. Cardiol. 94 (2004) 1196-1198
21. Ngo D.T., Wuttke R.D., Turner S., Marwick T.H., and Horowitz J.D. Quantitative assessment of aortic sclerosis using ultrasonic backscatter. J. Am. Soc. Echocardiogr. 17 (2004) 1123-1130
22. Ngo D.T., Heresztyn T., Mishra K., Marwick T.H., and Horowitz J.D. Aortic stenosis is associated with elevated plasma levels of asymmetric dimethylarginine (ADMA). Nitric Oxide: Biol. Chem. 16 (2007) 197-201
23. Nightingale A.K., and Horowitz J.D. Aortic sclerosis: not an innocent murmur but a marker of increased cardiovascular risk. Heart 91 (2005) 1389-1393
24. Ortlepp J.R., Hoffmann R., Ohme F., Lauscher J., Bleckmann F., and Hanrath P. The vitamin D receptor genotype predisposes to the development of calcific aortic valve stenosis. Heart 85 (2001) 635-638
25. Otto C.M., Kuusisto J., Reichenbach D.D., Gown A.M., and O'Brien K.D. Characterization of the early lesion of "degenerative" valvular aortic stenosis: histochemical and immunohistochemical studies. Circulation 90 (1994) 844-853
26. Otto C.M., Lind B.K., Kitzman D.W., Gersh B.J., and Siscovick D.S. Association of aortic-valve sclerosis with cardiovascular mortality and morbidity in the elderly. N. Eng. J. Med. 341 (1999) 142-147
27. Perkovic V., Hunt D., Griffin S.V., du Plessis M., and Becker G.J. Accelerated progression of calcific aortic stenosis in dialysis patients. Nephron Clin. Pract. 94 (2003) c40-c45
28. Rajamannan N.M., Sangiorgi G., Springett M., Arnold K., Mohacsi T., Spagnoli L.G., Edwards W.D., Tajik A.J., and Schwartz R.S. Experimental hypercholesterolemia induces apoptosis in the aortic valve. J. Heart Valve Dis. 10 (2001) 371-374
29. Rajamannan N.M., Subramaniam M., Stock S.R., Stone N.J., Springett M., Ignatiev K.I., McConnell J.P., Singh R.J., Bonow R.O., and Spelsberg T.C. Atorvastatin inhibits calcification and enhances nitric oxide synthase production in the hypercholesterolaemic aortic valve. Heart 91 (2005) 806-810
30. Schulze P.C., Liu H., Choe E., Yoshioka J., Shalev A., Bloch K.D., and Lee R.T. Nitric oxide-dependent suppression of thioredoxin-interacting protein expression enhances thioredoxin activity. Arterioscler. Thromb. Vasc. Biol. 26 (2006) 2666-2672
31. Scragg R., Khaw K.T., and Murphy S. Effect of winter oral vitamin D3 supplementation on cardiovascular risk factors in elderly adults. Eur. J. Clin. Nutr. 49 (1995) 640-646
32. Stewart B.F., Siscovick D., Lind B.K., Gardin J.M., Gottdiener J.S., Smith V.E., Kitzman D.W., and Otto C.M. Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study. J. Am. Coll. Cardiol. 29 (1997) 630-634
33. Tanaka K., Sata M., Fukuda D., Suematsu Y., Motomura N., Takamoto S., Hirata Y., and Nagai R. Age-associated aortic stenosis in apolipoprotein E-deficient mice. J. Am. Coll. Cardiol. 46 (2005) 134-141
34. Warren B.A., and Yong J.L.C. Calcification of the aortic valve: its progression and grading. Pathology 29 (1997) 360-368
35. Weiss R.M., Ohashi M., Miller J.D., Young S.G., and Heistad D.D. Calcific aortic valve stenosis in old hypercholesterolemic mice. Circulation 114 (2006) 2065-2069
36. Wongpraparut N., Apiyasawat S., Crespo G., Yazdani K., Jacobs L.E., and Kotler M.N. Determinants of progression of aortic stenosis in patients > or = 40 years. Am. J. Cardiol. 89 (2002) 350-352
37. Xiang G., Seki T., Schuster M.D., Witkowski P., Boyle A.J., See F., Martens T.P., Kocher A., Sondermeijer H., Krum H., and Itescu S. Catalytic degradation of vitamin D up-regulated protein 1 mRNA enhances cardiomyocyte survival and prevents left ventricular remodeling after myocardial ischemia. J. Biol. Chem. 280 (2005) 39394-39402